Transition Care for FEP
Adapting and Improving Transition Care for First Episode Psychosis
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 40 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 6 weeks
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "This team will then continue following the patient after discharge, maintaining contact with the individual, their caregivers, and the CSC program they are referred to, for up to 6 weeks or until attendance of the CSC appointment."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests a Transition Care Team for people with a first episode of psychosis, which can make it hard to tell what is real. The team offers therapy and support in the hospital and after people leave. The study compares this program with usual care to see if more people start outpatient mental health care and feel and function better.
This study is testing a new approach to help people with first episode psychosis transition successfully from the hospital to outpatient mental health care. Many patients lose contact with services after they leave the hospital, which can lead to worse outcomes. The investigators have developed a Transition Care Team (TCT) that works with patients while they are in the hospital and continues to support them after discharge. The team provides therapy, case management, and coordination with community programs that offer ongoing care. The main goal of the study is to find out if this new program increases the number of patients who successfully begin outpatient treatment after hospitalization, compared to usual care. The investigators will also look at whether the program improves symptoms, functioning, and overall well-being.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Have schizophrenia, schizoaffective disorder, schizophreniform disorder, another listed psychosis diagnosis, or bipolar disorder or major depression with psychosis.
- Have had the psychotic disorder diagnosis for less than 2 years.
- Be able to read, speak, and understand English.
- Be able and willing to give written consent to join, or written agreement if a caregiver is your legal guardian.
- Have an estimated IQ above 65, based on a reading test.
- Caregivers must be identified by you or your care team as helping plan your hospital discharge or follow-up care.
- Caregivers must be able to give spoken consent and speak and read English well enough to complete study forms. They may be family, close supports, or legal representatives.
Who can't join
- Have psychosis caused by substance use or a medical condition.
- Do not meet the study's requirements for a first episode of psychosis.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder with psychotic features, major depressive disorder with psychotic features, schizophreniform disorder, or psychosis NOS * The diagnosis of one of the psychotic disorders has a duration of less than two years. * Able to read, speak, and understand English, which will be assessed through observation. * Able and willing to provide written informed consent or assent, in cases where caregivers are considered legal guardians. Dr. Shima, co-I of the study, is a forensic psychiatrist, and particularly adept at judging such ability. Drs. Erickson and Keedy have conducted studies in individuals with psychotic disorders, including FEP and in the context of clinical trials, for years, and are similarly competent to judge whether individuals can provide informed consent. Finally, we will also use an Evaluation to Sign Consent form that documents subjects' verbalized understanding of key aspects of the study. * have an estimated IQ of \> 65, assessed by the Wechsler Test of Adult Reading * Eligible caregivers/proxy informants must be identified by the participant or clinical team as being involved in the participant's discharge planning or follow-up care, be able to provide informed verbal consent, and be able to speak and read English sufficiently to complete study questionnaires. Caregivers may include family members, close supports, or legally authorized representatives. Exclusion Criteria: * Individuals with substance-induced psychosis or psychosis due to a medical condition will not be included in the study. We will use the Structured Clinical Interview for DSM-5 as well as medical records, and if the subject gives permission, caregiver information in this process * Individuals who do not meet criteria for a first episode of psychosis
Study sites (2)
IL
- University of Chicago Medical Center, Biological Science Division · Chicago, IL 60637More trials in Chicago
- University of Chicago Ingalls Memorial Hospital · Harvey, IL 60426Madeline Perez, B.S · Study contact · 773-712-9178 · maddieg@bsd.uchicago.eduCarolyn Shima, PhD · Sub-investigatorSarah Keedy, PhD · Principal investigatorMolly Erickson, PhD · Sub-investigatorMore trials in Harvey